ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Andrew S. Wechsler
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wechsler, A. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wechsler, A. S.
Related Collections
Right arrowRelated Article

Ann Thorac Surg 1995;60:497-498
© 1995 The Society of Thoracic Surgeons


Editorials

Molecular Biology 101

Andrew S. Wechsler, MD

Department of Surgery, Medical College of Virginia, Richmond, Virginia

The first 20% of the full text of this article appears below.

In this issue of The Annals,Rowland and co-workers [1] call our attention to some of the strategies potentially useful for gene therapy. The concept of altering the control of cellular protein products through the process of gene manipulation is not new. The potential for clinical application of this strategy is, however, more realistic with every passing day.

Gene therapy is but one of the novel tools to emerge from the development of the branch of science termed molecular biology. Molecular biology is, in fact, a composite of two important pieces. The first of these is the collection of a series of biochemical techniques that facilitate understanding and manipulation of the genomic environment of the cell. The second component is conceptual. It changes our focus from primary manipulation of proteins by studying or manufacturing them exogenously and interacting with them (as with a monoclonal antibody), to an approach that manipulates cell proteins by using the nucleic acid base coding that is ultimately responsible for their production and degradation. In essence, this approach mimics . . . [Full Text of this Article]


Related Article

Potential Gene Therapy Strategies in the Treatment of Cardiovascular Disease
Robert T. Rowland, Joseph C. Cleveland, Jr, Xianzhong Meng, Alden H. Harken, and James M. Brown
Ann. Thorac. Surg. 1995 60: 721-728. [Abstract] [Full Text]



This article has been cited by other articles:


Home page
PerfusionHome page
A. Basile-Borgia, J. H Abel, and H. Mahloogi
Molecular advances in cardiac and cardiovascular disease
Perfusion, March 1, 1999; 14(2): 89 - 99.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1995 by The Society of Thoracic Surgeons.